ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
Alec Vaezi1,2, Chelsea H Feldman2, Laura J Niedernhofer2,31Department of Otolaryngology and Head and Neck Surgery, University of Pittsburgh School of Medicine, 2University of Pittsburgh Cancer Institute, 3Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine...
Saved in:
Main Authors: | Vaezi A (Author), Feldman CH (Author), Niedernhofer LJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarker for colorectal carcinoma -ERCC1-New kid on the block
by: Nalini Bansal
Published: (2019) -
<i>ERCC1</i> and <i>ERCC2</i> Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
by: Andrés Barba, et al.
Published: (2024) -
Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer
by: T. M. Zavarykina, et al.
Published: (2023) -
The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
by: Hadeel Obiedat, et al.
Published: (2018) -
Identification of polymorphisms of XRCC1 gene in patients with cancer in a city of northern Brazil
by: Artemis Socorro N. Rodrigues, et al.
Published: (2015)